Related Experiment Videos
Flow cytometry susceptibility testing for the antifungal caspofungin
M Mitchell1, M Hudspeth, A Wright
1Microbiology Department, Community Medical Centers-Fresno, Fresno, CA 93701, USA. mmitchell@communitymedical.org
Journal of Clinical Microbiology
|June 16, 2005
Summary
Flow cytometry (FC) offers rapid antifungal susceptibility testing for caspofungin. This 7-hour FC method provides results comparable to standard protocols for Candida species, aiding faster clinical decisions.
Area of Science:
- Medical Mycology
- Clinical Microbiology
- Flow Cytometry Applications
Background:
- Antifungal susceptibility testing (AFST) is crucial for guiding treatment of Candida infections.
- Standard AFST methods, like NCCLS M27-A2, can be time-consuming.
- Development of rapid diagnostic methods is needed for timely clinical intervention.
Purpose of the Study:
- To evaluate the consistency and accuracy of a rapid flow cytometry (FC) method for determining caspofungin susceptibility in Candida species.
- To compare FC-derived minimum inhibitory concentrations (MICs) with those obtained from the standard NCCLS M27-A2 protocol.
Main Methods:
- A flow cytometry (FC) procedure using acridine orange was developed for rapid antifungal susceptibility testing.
- Seventy-three clinical isolates of eight Candida species were tested.
- MICs determined by FC were compared to those obtained using the standard macrotiter or microdilution NCCLS M27-A2 protocol.
Main Results:
- The FC method provided caspofungin MIC results within 7 to 9 hours.
- Ninety percent of the FC results showed excellent agreement with the NCCLS M27-A2 protocol, differing by only one dilution.
- All tested isolates fell within the sensitive interpretive category for caspofungin, with comparable MIC50 and MIC90 values between methods.
Conclusions:
- The rapid 7-hour flow cytometry protocol is a reliable and consistent method for determining caspofungin susceptibility in Candida species.
- This FC method yields results equivalent to the standard NCCLS M27-A2 protocol, offering a faster alternative for clinical laboratories.